Assyro AI

Orange Book product · Generic (ANDA)

OSELTAMIVIR PHOSPHATE

OSELTAMIVIR PHOSPHATE

Generic (ANDA)ANDA 214949DISCN LEADING
View OSELTAMIVIR PHOSPHATE familyOpen on FDA Orange Book

At a glance

Feb 28, 2022

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 28, 2022

    4 yr 4 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

OSELTAMIVIR PHOSPHATE

Strength

EQ 6MG BASE/ML

Dosage form

FOR SUSPENSION

Route

ORAL

TE code

Not listed

Application

ANDA 214949

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of OSELTAMIVIR PHOSPHATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo